Work

Intravenous loop diuretic timing and renal outcomes after cardiac surgery-associated acute kidney injury

Year: 2026
Type: article
Study design: Observational Study
Abstract: Intravenous loop diuretics are frequently used for fluid removal after cardiac surgery-associated acute kidney injury (CSA-AKI), but the implications of initiation timing remain uncertain. We used MIMIC-IV v3.1 in a retrospective observational study informed by target-trial principles. Adults with AKI after cardiac surgery were assigned time zero at the first qualifying KDIGO AKI timestamp and classified by qualifying intravenous loop diuretic exposure timing within 72 h: Early (active at T0 or initiated within 0–24 h), Late (> 24–72 h), or None. The primary outcome was Day-7 renal recovery; secondary outcomes included Day-30 recovery, persistent AKI, acute kidney disease, and MAKE30. Stabilized inverse-probability-of-treatment weights from a multinomial propensity-score model were truncated at the 99.5th percentile. Among 6,289 patients, Early versus None showed no clear difference in Day-7 renal recovery (74.8 vs. 74.0%; risk difference, 0.77% points; 95% CI, −3.30 to 4.94). This finding remained compatible with the null in the propensity-score-refit bootstrap (95% CI, −3.59 to 5.18) and a 72-hour survivor-restricted analysis (risk difference, 0.27% points; 95% CI, −3.76 to 4.36). Secondary Early-versus-Late contrasts showed differences for some outcomes but were exploratory and statistically fragile given the small Late group, and they do not override the primary comparison, which showed no clear benefit or harm.
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7226008885
FWCI:
Cites: 17
Cited by:
Related to: 10